$CUEN
Cuentas Inc. Stock $cuen

$cuen Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023088510 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$1.346M	$895.0K	$787.0K
YoY Change	71.03%	-21.7%	656.73%
Cost Of Revenue	$1.486M	$971.0K	$606.0K
YoY Change	145.21%	-5.45%	461.11%
Gross Profit	-$140.0K	-$76.00K	$181.0K
YoY Change	-177.35%	-165.52%	-4625.0%
Gross Profit Margin	-10.4%	-8.49%	23.0%
Selling, General & Admin	$2.512M	$1.097M	$1.469M
YoY Change	71.0%	-43.13%	-64.97%
% of Gross Profit			811.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.000K	$4.000K	$455.0K
YoY Change	-99.78%	-99.12%	0.22%
% of Gross Profit			251.38%
Operating Expenses	$2.510M	$1.104M	$1.921M
YoY Change	30.66%	-53.65%	-58.64%
Operating Profit	-$2.650M	-$1.180M	-$1.740M
YoY Change	52.3%	-47.93%	-62.57%
Interest Expense	$4.715M	-$2.000K	$10.00K
YoY Change	47050.0%	-300.0%	66.67%
% of Operating Profit
Other Income/Expense, Net	$96.00K	-$2.000K	-$100.0K
YoY Change	-196.0%	-300.0%	9900.0%
Pretax Income	$2.161M	-$1.182M	-$5.430M
YoY Change	-139.8%	-47.81%	16.93%
Income Tax
% Of Pretax Income
Net Earnings	$2.098M	-$1.187M	-$5.446M
YoY Change	-138.52%	-47.82%	17.22%
Net Earnings / Revenue	155.87%	-132.63%	-691.99%
Basic Earnings Per Share		-$0.53
Diluted Earnings Per Share	$0.67	-$0.53	-$3.95
COMMON SHARES
Basic Shares Outstanding	2.720M shares	2.103M shares	16.72M shares
Diluted Shares Outstanding		2.228M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$205.0K	$1.057M	$466.0K
YoY Change	-56.01%	-49.86%	-92.95%
Cash & Equivalents	$205.0K	$1.057M	$466.0K
Short-Term Investments
Other Short-Term Assets	$76.00K	$94.00K	$14.00K
YoY Change	442.86%	64.91%	-91.36%
Inventory
Prepaid Expenses
Receivables	$7.000K	$860.0K	$209.0K
Other Receivables	$1.472M	$1.055M	$0.00
Total Short-Term Assets	$1.760M	$2.105M	$689.0K
YoY Change	155.44%	-13.34%	-89.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.00K	$4.000K	$6.000K
YoY Change	116.67%	-55.56%	200.0%
Goodwill
YoY Change
Intangibles	$19.00K	$168.0K	$28.00K
YoY Change	-32.14%	-95.88%	-99.49%
Long-Term Investments	$2.928M	$3.000M	$776.0K
YoY Change	277.32%	236.32%	1942.11%
Other Assets
YoY Change
Total Long-Term Assets	$2.960M	$3.172M	$810.0K
YoY Change	265.43%	-36.32%	-85.21%
TOTAL ASSETS
Total Short-Term Assets	$1.760M	$2.105M	$689.0K
Total Long-Term Assets	$2.960M	$3.172M	$810.0K
Total Assets	$4.720M	$5.277M	$1.499M
YoY Change	214.88%	-28.79%	-87.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.497M	$1.412M	$1.231M
YoY Change	21.61%	16.12%	51.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$26.00K	$118.0K	$109.0K
YoY Change	-76.15%	11.32%	12.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.689M	$3.186M	$2.134M
YoY Change	119.73%	17.13%	-21.52%
LONG-TERM LIABILITIES
Long-Term Debt	$101.0K	$89.00K	$89.00K
YoY Change	13.48%	0.0%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$101.0K	$89.00K	$89.00K
YoY Change	13.48%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.689M	$3.186M	$2.134M
Total Long-Term Liabilities	$101.0K	$89.00K	$89.00K
Total Liabilities	$4.790M	$3.275M	$2.223M
YoY Change	115.47%	16.59%	-20.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$54.95M	-$57.04M	-$52.75M
YoY Change	4.16%	20.59%	38.02%
Common Stock	$54.91M	$59.08M	$19.00K
YoY Change	288894.74%	347423.53%	26.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$29.00K
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.500M	$2.002M	-$724.0K
YoY Change
Total Liabilities & Shareholders Equity	$4.720M	$5.277M	$1.499M
YoY Change	214.88%	-28.79%	-87.77%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	$2.098M	-$1.187M	-$5.446M
YoY Change	-138.52%	-47.82%	17.22%
Depreciation, Depletion And Amortization	$1.000K	$4.000K	$455.0K
YoY Change	-99.78%	-99.12%	0.22%
Cash From Operating Activities	-$992.0K	-$851.0K	-$1.614M
YoY Change	-38.54%	-64.21%	-23.25%
INVESTING ACTIVITIES
Capital Expenditures	$161.0K	$73.00K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$301.0K	-$5.000K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$140.0K	-$78.00K	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	1.710M	-28.00K
YoY Change	-100.0%	-36.38%
NET CHANGE
Cash From Operating Activities	-992.0K	-851.0K	-1.614M
Cash From Investing Activities	140.0K	-78.00K	0.000
Cash From Financing Activities	0.000	1.710M	-28.00K
Net Change In Cash	-852.0K	781.0K	-1.642M
YoY Change	-48.11%	151.94%	-23.38%
FREE CASH FLOW
Cash From Operating Activities	-$992.0K	-$851.0K	-$1.614M
Capital Expenditures	$161.0K	$73.00K	$0.00
Free Cash Flow	-$1.153M	-$924.0K	-$1.614M
YoY Change	-28.56%	-61.14%	-23.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2227973	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39973
	dei	Entity Registrant Name EntityRegistrantName	CUENTAS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3537265
	dei	Entity Address Address Line1 EntityAddressAddressLine1	235 Lincoln Rd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	611-3622
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2719668	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1057000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	466000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	860000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	94000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	14000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2105000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	689000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6000	usd
CY2023Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3000000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	776000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	168000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28000	usd
CY2023Q3	us-gaap	Assets Assets	5277000	usd
CY2022Q4	us-gaap	Assets Assets	1499000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1412000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1231000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1526000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	681000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	113000	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	118000	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	109000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3186000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2134000	usd
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	89000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	89000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3275000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2223000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11076923	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11076923	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2719668	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2719668	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1473645	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1473645	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	59074000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	52051000	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	33000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	29000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57044000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52750000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2002000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-724000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5277000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1499000	usd
	us-gaap	Revenues Revenues	1000000	usd
	us-gaap	Revenues Revenues	2207000	usd
CY2023Q3	us-gaap	Revenues Revenues	895000	usd
CY2022Q3	us-gaap	Revenues Revenues	1143000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1247000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1902000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	971000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1027000	usd
	us-gaap	Gross Profit GrossProfit	-247000	usd
	us-gaap	Gross Profit GrossProfit	305000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-76000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	116000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1358000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	453000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3499000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7962000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1097000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1929000	usd
	us-gaap	Operating Expenses OperatingExpenses	3512000	usd
	us-gaap	Operating Expenses OperatingExpenses	9320000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1104000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2382000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3759000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9015000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1180000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2266000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-537000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-32000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
	cuen	Gain On Fair Value Measurement Of Stock Based Liabilities GainOnFairValueMeasurementOfStockBasedLiabilities	1000	usd
CY2023Q3	cuen	Gain On Fair Value Measurement Of Stock Based Liabilities GainOnFairValueMeasurementOfStockBasedLiabilities	1000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-511000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-34000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4270000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9049000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1182000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2265000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-24000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-36000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4294000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9085000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1187000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2275000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.69
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.84
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2052604	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1180986	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2227973	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1233624	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-724000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6034000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	290000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	700000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4294000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2002000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1471000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1715000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1187000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2002000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9450000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	881000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	667000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9085000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4601000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3844000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	344000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2275000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4601000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4294000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9085000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	290000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1548000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-24000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-36000	usd
	us-gaap	Interest Expense InterestExpense	9000	usd
	us-gaap	Interest Expense InterestExpense	9000	usd
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	537000	usd
	cuen	Gain From Changes In On Fair Value Of Stockbased Liabilities GainFromChangesInOnFairValueOfStockbasedLiabilities	2000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1358000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	651000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	486000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-105000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	106000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	406000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	879000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-136000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-127000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	17000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-276000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3201000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6523000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	2085000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	657000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	153000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2238000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-664000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6034000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2688000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6030000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2688000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	591000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4499000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	466000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6607000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1057000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2108000	usd
	cuen	Investment In Nonconsolidated Entity In Nonconsolidated Entity Against Accounts Receivables InvestmentInNonconsolidatedEntityInNonconsolidatedEntityAgainstAccountsReceivables	233000	usd
	us-gaap	Stock Issued1 StockIssued1	700000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cuentas, Inc. (the “Company”) together with its subsidiaries, is mainly focused on financial technology (“FINTECH”) services, delivering mobile financial services, prepaid debit and digital content services to unbanked, underbanked and underserved communities. During 2023-Q1, the Company initiated its first investment into the Real Estate market and, made its second, more significant investment in Real Estate in the second quarter of 2023. The Company derived its revenue from GPR “Debit” Card fees and the sales of prepaid products and services including third party digital content, gift cards, remittances, mobile phone topups and other digital services. Additionally, the Company has an agreement with Interactive Communications International, Inc. (“InComm”) a leading processor of general purpose reloadable (“GPR”) debit cards, to market and distribute a line of prepaid digital content and gift cards targeted towards the Latin American market. Cuentas is able to purchase InComm’s prepaid digital content and gift cards at a discount and resell these same products in real time through its mobile app and through the Cuentas SDI network of over 31,000 bodegas. Cuentas is able to offer these digital products to the public through its mobile app and the Cuentas SDI distribution network, many at discounted prices, while making a small profit margin which varies from product to product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company was incorporated under the laws of the State of Florida on September 21, 2005 to act as a holding company for its subsidiaries. Its subsidiary is Meimoun and Mammon, LLC (100% owned) (“M&M”), Tel3, a business segment of the Company, provides prepaid calling cards to consumers directly and operates in a complimentary space as Meimoun and Mammon, LLC. The Company invested $46, of which $20 were invested during 2023, for 50% of CUENTASMAX LLC which installs WiFi6 shared network (“WSN”) systems in locations in the New York metropolitan tristate area using access points and small cells to provide users with access to the WSN.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 3, 2023, the Company entered into a Membership Interest Purchase Agreement (MIPA) with Core Development Holdings Corporation (“Core”). Core holds approximately 29.3% of 4280 Lakewood Road Manager, LLC (“Lakewood Manager”), which in turn owns 86.45% of the membership interests in 4280 Lakewood Road, LLC (“4280 Project”), an affordable multi-family real estate project located in Lake Worth, Florida. Core agreed to sell to the Company 6% of its interest in the Lakewood Manager to the Company in exchange for 295,282 shares of the Company’s common stock, representing 19.99% of the then outstanding shares of the Company’s common stock. The 6% equity in the Lakewood Manager was valued at approximately $700. The Company closed this transaction on or about March 9, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The company used the measurement alternative which provides an accounting framework for valuing an equity security investment in the absence of a readily determinable fair value. Accordingly, the investment was accounted for at a cost basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On April 13, 2023, the Company signed an Operating Agreement to be a majority member in Brooksville Development Partners, LLC (“Brooksville”) with 2 minority members for the purpose of acquiring land for the development of a residential apartment community consisting of approximately 360 apartments. All real and personal property owned by Brooksville shall be owned by Brooksville as an entity, and neither the Members nor the Manager will have any ownership interest in such property. One of the minority members will be the manager of the project.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On April 28, 2023, the Company and minority partners in Brooksville closed on the transaction to acquire a 21.8 acre site for development of the Brooksville project. The Company had deposited an “Initial Capital Contribution” of $2,000 into a title insurance escrow account which was released from escrow by the Title Agent to fund the balance of the purchase price of the Vacant Land, together with a $3,050 bank loan to Brooksville from Republic Bank of Chicago. The Company is currently a 63% interest holder in Brooksville but that may change in the future if the Company is not able to raise sufficient financing to complete the project. Since the Company does not manage or control the LLC and its losses are limited to the cost amount, the Brooksville transaction was accounted for as an investment in an unconsolidated entity in accordance with ASC 323, using the equity method of accounting with the Company as the acquirer. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NASDAQ</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June 21, 2022, the Nasdaq Listing Qualifications Staff (the “Staff”) issued the Company a delist letter citing its failure to comply with the minimum bid price requirement under Listing Rule 5550(a)(2). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until December 19, 2022, to regain compliance with Rule 5550(a)(2). On December 20, 2022, the Staff notified the Company that it had determined to delist the Company as it did not comply with bid price requirement for listing on the Exchange. On April 14, 2023, the Nasdaq Listing Qualifications Staff issued the Company a compliance letter citing that that the Company had regained compliance with the minimum bid price requirement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 18, 2023, the Company received a deficiency letter from Nasdaq Regulation stating that based upon its Quarterly Report on Form 10-Q for the period ended June 30, 2023 which reported shareholders’ equity of $1,471, the Company was not in compliance with Nasdaq Marketplace Rule 5550(b)(1) which requires the Company to maintain shareholders’ equity of not less than $2,500 for continued listing on The Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On October 3 2023, the Company received a Staff Determination Letter from Nasdaq Regulation stating that due to the Company’s failure by October 2, 2023, to submit a plan to regain compliance with Nasdaq Listing Rule 5550(b)(1), the $2,500 stockholders’ equity requirement, the Company would be subject to delisting unless it timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). The Company has requested a hearing before the Panel which is scheduled to be held on December 7, 2023. The hearing request will stay any suspension or delisting action through the hearing and the expiration of any additional extension granted by the Panel following the hearing. In that regard, pursuant to the Nasdaq Listing Rules, the Panel has the discretion to grant the Company an extension not to exceed April 1, 2024. Notwithstanding, there can be no assurance that the Panel will grant the Company an extension or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">REVERSE SPLIT</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On March 24, 2023, the Company completed a reverse stock split of its common stock. As a result of the reverse stock split, the following changes have occurred (i) every thirteen shares of common stock have been combined into one share of common stock; (ii)</span> the number of authorized shares of common stock has been proportionately reduced; (iii) <span style="font-family: Times New Roman, Times, Serif">the number of shares of common stock underlying each common stock option or common stock warrant have been proportionately decreased on a 1-for-13 basis, and (iv) the exercise price of each such outstanding stock option and common warrant has been proportionately increased on a 1-for-13 basis. Accordingly, all option numbers, share numbers, warrant numbers, share prices, warrant prices, exercise prices and losses per share have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 1-for-13 reverse stock split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">GOING CONCERN</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2023, the Company had $1,057 in cash and cash equivalents, $1,081 in negative working capital, shareholder’s equity of $2,002 and an accumulated deficit of $57,044. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. Management anticipates their business will require substantial additional investments that have not yet been secured. Management is continuing in the process of fund raising in the private equity and capital markets as the Company will need to finance future activities. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SECURITIES OFFERING</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 6, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the purpose of raising approximately $5,000 in gross proceeds for the Company. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell, in a registered direct offering, an aggregate of (i) 163,344 shares (the “Shares”) of the Company’s common stock (“Common Stock”) and (ii) pre-warrants to purchase up to 128,031 shares of Common Stock (the “Pre-Funded Warrants” and such shares of Common Stock issuable upon exercise of the Pre-Funded Warrants, the “Pre-Funded Warrant Shares”) and, in a concurrent private placement, warrants (the “Purchase Warrants”) to purchase 291,375 shares of Common Stock (the shares of Common Stock issuable upon exercise of the Purchase Warrants, the “Purchase Warrant Shares”). The combined purchase price per Share and Purchase Warrant is $17.16 and the combined purchase price per Pre-Funded Warrant and Purchase Warrant of $17.16. The Pre-Funded Warrants were sold, in lieu of shares of Common Stock, to any Investor whose purchase of shares of Common Stock in the Registered Offering would otherwise result in such Investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at such Investor’s option upon issuance, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering. Each Pre-Funded Warrant represents the right to purchase one share of Common Stock at an exercise price of $0.0013 per share. As of March 31, 2023 the Pre-Funded Warrants were exercised in full. The Purchase Warrants will be exercisable on or before August 5, 2023 and will expire on August 5, 2028 at an exercise price of $17.36 per share. The closing of the sales of these securities under the Purchase Agreement occurred on or about February 8, 2023. H.C. Wainwright & Co., LLC (“Wainwright”) acted as exclusive placement agent for the offering pursuant to an engagement agreement between the Company and Wainwright dated as of December 13, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As compensation for such placement agent services, the Company agreed to pay Wainwright an aggregate cash fee equal to 7.0% of the gross proceeds received by the Company from the offering, plus a management fee equal to 1.0% of the gross proceeds received by the Company from the offerings, a non-accountable expense of $65 and $16 for clearing expenses. The Company has also agreed to issue to Wainwright or its designees warrants to purchase 20,397 shares of Common Stock (the “PA Warrants” and the shares of Common Stock issuable upon exercise of the PA Warrants, the “PA Warrant Shares”). The PA Warrants have a term of five years from the issuance date and have an exercise price of $23.17 per share. The net proceeds to the Company from the registered direct offering and concurrent private placement, after deducting the Placement Agent’s fees and expenses and the Company’s offering expenses were $4,319.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2023, the Company entered into a common stock warrant exercise inducement offer letter (the “Inducement Letter”) with a certain holder (the “Holder”) of existing warrants to purchase shares of the Company’s common stock at an exercise price of $7.67 per share, issued on August 8, 2022 and of the Purchase Warrants having an exercise price of $17.16 per share which were issued on February 8, 2023 (together, the “Existing Warrants”). Pursuant to the Inducement Letter, the Holder agreed to exercise for cash its Existing Warrants to purchase an aggregate of 616,303 shares of the Company’s common stock, at a reduced exercised price of $3.30 per share, in consideration for the Company’s agreement to issue a new warrant (the “Inducement Warrant”), to purchase up to 1,232,606 shares of the Company’s common stock at an exercise price of $3.30, </span><span style="font-size: 10pt">subject to certain anti-dilution adjustments. The Inducement Warrant is exercisable for five and a half years commencing on the date shareholders of the Company approve the issuance of the Inducement Warrant (“Shareholder Approval”) under applicable rules of Nasdaq<span style="font-family: Times New Roman, Times, Serif">. The Company received aggregate gross proceeds of approximately $2,033,799 from the exercise of the Existing Warrants by the Holder and the sale of the Inducement Warrants, before deducting placement agent fees and other offering expenses payable by the Company. The Company engaged H.C. Wainwright & Co., LLC (“Wainwright”) to act as its exclusive placement agent in connection with the transactions summarized above and paid Wainwright a cash fee </span>of $142,366 <span style="font-family: Times New Roman, Times, Serif">(7.0% of the gross proceeds received from the exercise of the Existing Warrants) as well as a management fee </span></span>of $20,338 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.0% of the gross proceeds from the exercise of the Existing Warrants). The Company </span>also paid <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wainwright $65,000 for non-accountable expenses and $15,950 as a closing fee. The Company also issued to </span>designees of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wainwright warrants to purchase up to </span>an aggregate of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,141 shares of common stock of the Company having the same terms as the Inducement Warrant except for an exercise price equal to $4.455 per share.</span></p>
CY2023Q3	cuen	Cuentas Sdi Network Of Over Bodegas CuentasSDINetworkOfOverBodegas	31000	pure
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	46	usd
	cuen	Purchase Agreement Description PurchaseAgreementDescription	the Company entered into a Membership Interest Purchase Agreement (MIPA) with Core Development Holdings Corporation (“Core”). Core holds approximately 29.3% of 4280 Lakewood Road Manager, LLC (“Lakewood Manager”), which in turn owns 86.45% of the membership interests in 4280 Lakewood Road, LLC (“4280 Project”), an affordable multi-family real estate project located in Lake Worth, Florida. Core agreed to sell to the Company 6% of its interest in the Lakewood Manager to the Company in exchange for 295,282 shares of the Company’s common stock, representing 19.99% of the then outstanding shares of the Company’s common stock. The 6% equity in the Lakewood Manager was valued at approximately $700. The Company closed this transaction on or about March 9, 2023.
CY2023Q2	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	2000000	usd
CY2023Q2	us-gaap	Other Borrowings OtherBorrowings	3050000	usd
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.63	pure
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	1471000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	2500	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2500000	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	As a result of the reverse stock split, the following changes have occurred (i) every thirteen shares of common stock have been combined into one share of common stock; (ii) the number of authorized shares of common stock has been proportionately reduced; (iii) the number of shares of common stock underlying each common stock option or common stock warrant have been proportionately decreased on a 1-for-13 basis, and (iv) the exercise price of each such outstanding stock option and common warrant has been proportionately increased on a 1-for-13 basis. Accordingly, all option numbers, share numbers, warrant numbers, share prices, warrant prices, exercise prices and losses per share have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 1-for-13 reverse stock split.
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1057000	usd
	cuen	Working Capital WorkingCapital	1081000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2002000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57044000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	5000000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	163344	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	128031	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	17.16
CY2023Q1	us-gaap	Sale Of Stock Percentage Of Ownership Before Transaction SaleOfStockPercentageOfOwnershipBeforeTransaction	0.0499	pure
CY2023Q1	cuen	Investor Percentage InvestorPercentage	0.0999	pure
CY2023Q1	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	0.0013
CY2023Q3	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	17.36
	cuen	Cash Fee Equal Percentage CashFeeEqualPercentage	0.07	pure
	cuen	Nonaccountable Expense nonaccountableExpense	65000	usd
	cuen	Clearing Expenses ClearingExpenses	16000	usd
	cuen	Warrant Term WarrantTerm	P5Y
CY2023Q3	cuen	Offering Expenses OfferingExpenses	4319000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.67
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	17.16
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	616303	shares
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2033799000	usd
CY2023Q1	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	142366000	usd
CY2023Q1	cuen	Cash Fee Gross Proceeds CashFeeGrossProceeds	0.07	pure
CY2023Q1	cuen	Management Fees ManagementFees	20338000	usd
CY2023Q1	cuen	Management Fee ManagementFee	0.01	pure
CY2023Q1	cuen	Non Accountable Expenses NonAccountableExpenses	65000000	usd
CY2023Q1	cuen	Closing Fee ClosingFee	15950000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.455
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.</p>
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	128477	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.44
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8862	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	186.55
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	119615	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.86
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	115766	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36820
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1400	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	912000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1634000	usd
CY2023Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	882000	usd
CY2022Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	902000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	94000	usd
	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	860000	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	198000	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1055000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	198000	usd
CY2019Q2	us-gaap	Other Receivables OtherReceivables	1053000	usd
CY2021Q3	us-gaap	Affiliate Costs AffiliateCosts	600000	usd
	cuen	Accrued Amount AccruedAmount	300000	usd
CY2022Q4	us-gaap	Product Liability Contingency Loss Exposure In Excess Of Accrual Best Estimate ProductLiabilityContingencyLossExposureInExcessOfAccrualBestEstimate	630000	usd
	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	20000	usd
	us-gaap	Payments For Fees PaymentsForFees	15000	usd
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	425000	usd
CY2023Q3	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	115000	usd
CY2023Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	30	usd
CY2021Q2	us-gaap	Payments For Rent PaymentsForRent	9000	usd
CY2023Q3	cuen	Payment Of Outstanding Invoice PaymentOfOutstandingInvoice	229000	usd
CY2023Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	21000	usd
	us-gaap	Revenues Revenues	1000000	usd
	us-gaap	Revenues Revenues	2207000	usd
CY2023Q3	us-gaap	Revenues Revenues	895000	usd
CY2022Q3	us-gaap	Revenues Revenues	1143000	usd
	us-gaap	Gross Profit GrossProfit	-247000	usd
	us-gaap	Gross Profit GrossProfit	305000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-76000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	116000	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	537000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	850000	usd
CY2023Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	537000	usd
	cuen	Gain On Fair Value Measurement Of Stock Based Liabilities GainOnFairValueMeasurementOfStockBasedLiabilities		usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	cuen	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits		usd
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	cuen	Investment In Nonconsolidated Entity In Nonconsolidated Entity Against Accounts Receivables InvestmentInNonconsolidatedEntityInNonconsolidatedEntityAgainstAccountsReceivables		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Other Receivables OtherReceivables		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001424657

Files In Submission

Name	View Source	Status
0001213900-23-088510-index-headers.html	Edgar Link	pending
0001213900-23-088510-index.html	Edgar Link	pending
0001213900-23-088510.txt	Edgar Link	pending
0001213900-23-088510-xbrl.zip	Edgar Link	pending
cuen-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_cuentasinc.htm	Edgar Link	pending
f10q0923ex31-2_cuentasinc.htm	Edgar Link	pending
f10q0923ex32-1_cuentasinc.htm	Edgar Link	pending
f10q0923ex32-2_cuentasinc.htm	Edgar Link	pending
f10q0923_cuentasinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
cuen-20230930_cal.xml	Edgar Link	unprocessable
cuen-20230930_pre.xml	Edgar Link	unprocessable
cuen-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cuen-20230930_lab.xml	Edgar Link	unprocessable
f10q0923_cuentasinc_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUEN
Cuentas Inc. Stock $cuen

2023 Q4 Form 10-Q Financial Statement

#000121390023088510 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUEN Cuentas Inc. Stock $cuen

2023 Q4 Form 10-Q Financial Statement

#000121390023088510 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUEN
Cuentas Inc. Stock $cuen